2022 ESMO Activity Summary

The START Center investigators contributed as authors to 21 posters and abstracts at

this year's ESMO meeting in Paris. Congratulations to the START physician team,

especially first authors Dr. Emiliano Calvo, Dr. Victor Moreno, and Dr. Manish

Sharma, for their contributions to the latest developments in oncology therapeutics.

With five sites and over 500 active and enrolling early-phase studies, the START

Center accelerates drug development, providing new, innovative anti-cancer drugs

across the globe to the patients that need it most.



44 views

Recent Posts

See All

First oncology early phase clinical trials unit in Portugal to offer leading-edge cancer treatments SAN ANTONIO, Aug. 16, 2022 - The START Center for Cancer Care, a San Antonio-based oncology early-ph